Viewing Study NCT01802632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-01-04 @ 3:36 AM
Study NCT ID: NCT01802632
Status: COMPLETED
Last Update Posted: 2024-01-18
First Post: 2013-02-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: AZD9291 First Time In Patients Ascending Dose Study
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Non Small Cell Lung Cancer View
None Advanced (Inoperable) Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Oncology, View
None Non Small Cell Lung Cancer, View
None Metastatic, View
None EGFR sensitivity mutation, View
None T790M resistance mutation View